Literature DB >> 7998929

Modulation of complement regulatory function and measles virus receptor function by the serine-threonine-rich domains of membrane cofactor protein (CD46).

K Iwata1, T Seya, S Ueda, H Ariga, S Nagasawa.   

Abstract

Three major membrane cofactor protein (MCP) phenotypes with different serine-threonine (ST)-rich regions, namely STc (L-phenotype), STBC (H or U phenotype) and STABC, and the MCP without the ST domain (delta ST) were expressed in Chinese hamster ovary (CHO) cells by transfecting the respective cDNAs. The expressed molecules migrated with a larger molecular mass on SDS/PAGE than those expected from their amino acid sequences. O-Glycanase digestion showed that this was due to O-linked sugar chains. The apparent sugar contents in each ST segment were compatible with their serine and threonine contents in the ST regions. The functional properties of these phenotypes as inhibitors of human complement (C) and receptors of measles virus (MV) were compared. The classical pathway-dependent CHO cell lysis by human C was more effectively suppressed by the expressed delta ST and STC than by the STABC and STBC phenotypes, although the difference was not so prominent. In contrast, alternative C pathway-dependent CHO-cell lysis was most effectively suppressed by the STABC phenotype and was only slightly blocked by the ST-deleted mutant. MV infection occurred with all of the phenotypes, but the infectious dose required to cause the same level of syncytium formation was 100-times higher in large ST (STABC and STBC) than in small ST (STC and delta ST) phenotypes. Thus, the ST domain serves as a functional modulator in MCP: MCP with a large ST domain having high O-linked sugar contents is favourable to the effective suppression of both the alternative C pathway-mediated cytolysis and MV infection, whereas MCP with a small ST domain is favourable to the suppression of the classical C pathway.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7998929      PMCID: PMC1137467          DOI: 10.1042/bj3040169

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Oligosaccharide structure of human C4.

Authors:  A C Chan; J P Atkinson
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

4.  The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA.

Authors:  T Yamamoto; C G Davis; M S Brown; W J Schneider; M L Casey; J L Goldstein; D W Russell
Journal:  Cell       Date:  1984-11       Impact factor: 41.582

5.  Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines.

Authors:  J L Cole; G A Housley; T R Dykman; R P MacDermott; J P Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

6.  A polymorphism of the complement regulatory protein MCP (membrane cofactor protein or gp45-70).

Authors:  L Ballard; T Seya; J Teckman; D M Lublin; J P Atkinson
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

7.  Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity.

Authors:  P Giraudon; T F Wild
Journal:  Virology       Date:  1985-07-15       Impact factor: 3.616

8.  Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.

Authors:  K Iwata; T Seya; H Ariga; S Nagasawa
Journal:  J Immunol       Date:  1994-04-01       Impact factor: 5.422

9.  Cleavage of C4b by C3b inactivator: production of a nicked form of C4b, C4b', as an intermediate cleavage product of C4b by C3b inactivator.

Authors:  S Nagasawa; C Ichihara; R M Stroud
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

10.  Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.

Authors:  T Seya; J R Turner; J P Atkinson
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

View more
  15 in total

1.  Productive measles virus brain infection and apoptosis in CD46 transgenic mice.

Authors:  A Evlashev; E Moyse; H Valentin; O Azocar; M C Trescol-Biémont; J C Marie; C Rabourdin-Combe; B Horvat
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Molecular remodelling of human CD46 for xenotransplantation: designing a potent complement regulator without measles virus receptor activity.

Authors:  N A Begum; Y Murakami; S Mikata; M Matsumoto; M Hatanaka; S Nagasawa; T Kinoshita; T Seya
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

3.  The Combination of gQ1 and gQ2 in Human Herpesvirus 6A and 6B Regulates the Viral Tetramer Function for Their Receptor Recognition.

Authors:  Aika Wakata; Lidya Handayani Tjan; Mitsuhiro Nishimura; Akiko Kawabata; Anna Lystia Poetranto; Chisato Yamamoto; Jun Arii; Yasuko Mori
Journal:  J Virol       Date:  2020-12-09       Impact factor: 5.103

4.  Molecular cloning of membrane cofactor protein (MCP; CD46) on B95a cell, an Epstein-Barr virus-transformed marmoset B cell line: B95a-MCP is susceptible to infection by the CAM, but not the Nagahata strain of the measles virus.

Authors:  Y Murakami; T Seya; M Kurita; A Fukui; S Ueda; S Nagasawa
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

5.  CD46 short consensus repeats III and IV enhance measles virus binding but impair soluble hemagglutinin binding.

Authors:  P Devaux; C J Buchholz; U Schneider; C Escoffier; R Cattaneo; D Gerlier
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

6.  Moesin is not a receptor for measles virus entry into mouse embryonic stem cells.

Authors:  Y Doi; M Kurita; M Matsumoto; T Kondo; T Noda; S Tsukita; S Tsukita; T Seya
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  Cell entry by measles virus: long hybrid receptors uncouple binding from membrane fusion.

Authors:  C J Buchholz; U Schneider; P Devaux; D Gerlier; R Cattaneo
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

8.  Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens.

Authors:  B David Persson; Nikolaus B Schmitz; César Santiago; Georg Zocher; Mykol Larvie; Ulrike Scheu; José M Casasnovas; Thilo Stehle
Journal:  PLoS Pathog       Date:  2010-09-30       Impact factor: 6.823

9.  Receptor (CD46) modulation and complement-mediated lysis of uninfected cells after contact with measles virus-infected cells.

Authors:  J Schneider-Schaulies; J J Schnorr; J Schlender; L M Dunster; S Schneider-Schaulies; V ter Meulen
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Human herpesvirus 6 variant A but not variant B induces fusion from without in a variety of human cells through a human herpesvirus 6 entry receptor, CD46.

Authors:  Yasuko Mori; Tsukasa Seya; Hong Lan Huang; Pilailuk Akkapaiboon; Panadda Dhepakson; Koichi Yamanishi
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.